NATERA, INC. Net Income (Loss) Available to Common Stockholders, Basic
NATERA, INC. (NTRA) reported Net Income (Loss) Available to Common Stockholders, Basic of -$547.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-03-01
- NATERA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was -$31.84M.
- NATERA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$29.62M.
- NATERA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$33.82M.
- NATERA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was -$32.87M.
- NATERA, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$547.80M.
- NATERA, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$471.72M.
- NATERA, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$229.74M.
- NATERA, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$124.83M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-12-31 | -$547.80M 10-K · filed 2023-03-01 | |||||
| 2021-12-31 | -$471.72M 10-K · filed 2023-03-01 | |||||
| 2020-12-31 | -$229.74M 10-K · filed 2023-03-01 | |||||
| 2019-12-31 | -$124.83M 10-K · filed 2022-02-25 | |||||
| 2018-12-31 | -$31.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$61.46M derived: sum of 2 quarters · filed 2020-03-02 | -$95.28M derived: sum of 3 quarters · filed 2020-03-02 | -$128.15M 10-K · filed 2020-03-02 | ||
| 2018-09-30 | -$29.62M 10-Q · filed 2018-11-09 | -$63.44M derived: sum of 2 quarters · filed 2018-11-09 | -$96.31M 10-Q · filed 2018-11-09 | -$143.53M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$33.82M 10-Q · filed 2018-08-09 | -$66.70M 10-Q · filed 2018-08-09 | -$113.91M derived: sum of 3 quarters · filed 2020-03-02 | -$141.78M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$32.87M 10-Q · filed 2018-05-10 | -$80.09M derived: sum of 2 quarters · filed 2020-03-02 | -$107.95M derived: sum of 3 quarters · filed 2020-03-02 | -$137.02M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$47.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$75.08M derived: sum of 2 quarters · filed 2020-03-02 | -$104.15M derived: sum of 3 quarters · filed 2020-03-02 | -$137.63M 10-K · filed 2020-03-02 | -$136.31M 10-K · filed 2018-03-15 | |
| 2017-09-30 | -$27.86M 10-Q · filed 2018-11-09 | -$56.93M derived: sum of 2 quarters · filed 2018-11-09 | -$90.41M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$29.07M 10-Q · filed 2018-08-09 | -$62.55M 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | -$33.48M 10-Q · filed 2018-05-10 | -$37.00M 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | -$100.33M 10-K · filed 2019-03-15 | -$95.77M 10-K · filed 2018-03-15 | ||||
| 2016-03-31 | -$8.69M 10-Q · filed 2017-05-10 | -$31.64M derived: sum of 2 quarters · filed 2018-03-15 | -$49.27M derived: sum of 3 quarters · filed 2018-03-15 | |||
| 2015-12-31 | -$22.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$40.59M derived: sum of 2 quarters · filed 2018-03-15 | -$70.28M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | -$17.63M 10-Q · filed 2015-11-13 | -$47.31M 10-Q · filed 2015-11-13 | ||||
| 2014-09-30 | $172.00K 10-Q · filed 2015-11-13 | -$6.41M 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |